Expert Ratings for CVS Health
Portfolio Pulse from Benzinga Insights
CVS Health (NYSE:CVS) has received 16 analyst ratings in the last quarter, with an average price target of $95.06, representing an upside from the current price of $68.64. The current average is a 12.48% decrease from the previous average price target of $108.62.

June 20, 2023 | 5:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
CVS Health has 16 analyst ratings with an average price target of $95.06, indicating an upside potential from its current price of $68.64.
The 16 analyst ratings for CVS Health show a bullish sentiment, with an average price target of $95.06, which is higher than the current price of $68.64. This indicates that the stock has potential for growth in the short term, based on the analysts' opinions. The relevance, importance, and confidence scores are high due to the direct mention of CVS Health and the focus on analyst ratings, which are significant factors for investors.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100